Skip to search.
 TSX Down 0.16% TSX Ventures  0.00%
Streaming
Ticker Tape: On

Acorda Therapeutics, Inc. (ACOR)

-NasdaqGS
35.25 Down 0.52(1.45%) Apr 23, 4:00PM EDT
|After Hours : 35.25 Down 0.00 (0.01%) Apr 23, 5:09PM EDT
Add to Portfolio
Prev Close:35.77
Open:35.78
Bid:29.52 x 100
Ask:36.77 x 100
1y Target Est:41.08
Beta:1.76
Next Earnings Date: 6-May-14ACOR Earnings announcement
Day's Range:34.79 - 36.26
52wk Range:27.51 - 39.95
Volume:311,033
Avg Vol (3m):508,624
Market Cap:1.44B
P/E (ttm):90.38
EPS (ttm):0.39
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Must Read

Comparison

Symbol% ChgMkt Cap
ACORDown 1.45%1.44B
BIIBUp 0.18%72.51B
TEVADown 1.52%42.97B

Key Statistics

Forward P/E (1 yr):40.52
P/S (ttm):4.35
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.53
Quarterly EPS Est (Mar-14) :0.09
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):1.68

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Acorda Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and commercializes novel therapies for multiple sclerosis (MS), spinal cord injury (SCI), and other disorders of the nervous system in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback